VOLIBO R 0.3/0.5MG TAB is used for Type 2 diabetes mellitus: to control post‑meal (postprandial) blood glucose in adults when diet and exercise alone or single therapy is inadequate..
Type 2 diabetes mellitus: to control post‑meal (postprandial) blood glucose in adults when diet and exercise alone or single therapy is inadequate.
How VOLIBO R 0.3/0.5MG TAB Works
Repaglinide stimulates the pancreas to release insulin quickly after meals, lowering blood glucose. Voglibose inhibits intestinal alpha‑glucosidase enzymes, delaying carbohydrate digestion and glucose absorption, thereby reducing post‑meal sugar spikes.
Dosage & Directions
Take by mouth exactly as prescribed. Usually taken shortly (about 15–30 minutes) before meals; if you skip a meal, skip that dose to reduce hypoglycaemia risk. Swallow with water; follow diet/exercise advice and monitor blood glucose as directed.
Always follow your doctor's prescription. Do not self-medicate.
Key Benefits
Reduces post‑meal blood sugar spikes
Improves overall glycaemic control in type 2 diabetes
Rapid mealtime glucose lowering
Helps when single therapy is insufficient
Pregnancy
Consult doctor (generally not recommended unless clearly needed; insulin is preferred in pregnancy).
Alcohol Interaction
Use with caution (can increase risk of hypoglycaemia).
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medicine.
